Consecutive non-Aspergillus Fungal Invasive Infections in Chronic Granulomatous Disease: Data from the French National Reference Center for Primary ImmunoDeficiencies and literature review
Journal of Clinical Immunology · 2025
DOI: 10.1007/s10875-025-01903-0 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Immunology, 2025. Verfasst von Leïla Lefevre und 34 weiteren Autor:innen. Beteiligte Einrichtung: Paris Cité University, Paris, France. Hauptthemen laut MEDLINE: Granulomatous Disease, Chronic, Invasive Fungal Infections. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 89 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
BACKGROUND: Non-Aspergillus invasive fungal infections (NAFI) are increasingly reported in patients with Chronic Granulomatous Disease (CGD), but precise clinical descriptions remain scarce. OBJECTIVE AND METHODS: We conducted a retrospective analysis of NAFI cases among CGD patients in the French National Registry of Primary Immunodeficiencies (CEREDIH) and in a comprehensive literature review. RESULTS: We identified 16 proven NAFI (9 molds, 6 yeasts and 1 Pneumocystis) among 263 CGD patients from CEREDIH and included an additional 106 probable/proven NAFI from a literature review (75 molds, 29 yeasts, 1 Pneumocystis, 1 dimorphic). Mold NAFI occurred at a median age of 17 years [IQR 9-23], and were mostly located to the lungs (79%, 65/82). Mold NAFI were breakthrough in 59% of patients (35/59), and 24% were receiving immunosuppressive treatments (13/54, mostly high-dose corticosteroids, n = 11). Lung surgical biopsies yielded the highest diagnostic rate (39/39) compared to less invasive methods (BAL 8/18 and transthoracic punctures 8/12). Nine patients with mold NAFI, including 3 refractory cases, were cured after Hematopoietic Stem Cell Transplantation (HSCT). Overall mortality for mold NAFI was 25% (20/81). Yeast infections occurred at a median age of 5 years [IQR 0-13], and 36% were receiving immunosuppressive treatments (5/14, mostly anti-TNF agents, n = 4). Infections were frequently located to lymph nodes or lungs, and 64% (21/33) were disseminated. Two yeast NAFI were cured after HSCT. Mortality was 26% (7/27). CONCLUSION: NAFI in CGD patients are frequently severe, often occur despite prophylaxis and under additional immunosuppression, commonly require invasive procedures for diagnosis, and may be effectively managed with HSCT.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Paris Cité University, Paris, France.
- Department of Infectious Diseases and Tropical Medicine, IHU Imagine, Necker Maladies University Hospital, Assistance Publique-Hôpitaux de Pairs (AP-HP), Paris, France.
- Pediatric Immunology, Hematology and Rheumatology Unit, Necker Enfants Malades University Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.
- French National Reference Centre for Primary ImmunoDeficiencies (CEREDIH), Necker University Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.
- Department of Mycology, Necker Enfants Malades University Hospital, Assistance Publique-Hôpitaux de Pairs (AP-HP), Paris, France.
- Department of Pathology, Necker Enfants Malades University Hospital, AP-HP, Paris, France.
Zitieren
APA
Lefevre, L., Paccoud, O., Neven, B., Bougnoux, M. E., Alligon, M., Bruneau, J., Fischer, A., Moshous, D., Bustamante, J., Picard, C., Poiree, S., Guery, R., Castelle, M., Suarez, F., Marcais, A., Cheminant, M., Rouzaud, C., Hermoso, D. G., Salvator, H., …, & Lanternier, F. (2025). Consecutive non-Aspergillus Fungal Invasive Infections in Chronic Granulomatous Disease: Data from the French National Reference Center for Primary ImmunoDeficiencies and literature review. Journal of Clinical Immunology. https://doi.org/10.1007/s10875-025-01903-0
Vancouver
Lefevre L, Paccoud O, Neven B, Bougnoux ME, Alligon M, Bruneau J, et al. Consecutive non-Aspergillus Fungal Invasive Infections in Chronic Granulomatous Disease: Data from the French National Reference Center for Primary ImmunoDeficiencies and literature review. Journal of Clinical Immunology. 2025. doi:10.1007/s10875-025-01903-0
BibTeX
@article{Lefevre2025,
author = {Lefevre, Leïla and Paccoud, Olivier and Neven, Bénédicte and Bougnoux, Marie-Elisabeth and Alligon, Mickaël and Bruneau, Julie and Fischer, Alain and Moshous, Despina and Bustamante, Jacinta and Picard, Capucine and Poiree, Sylvain and Guery, Romain and Castelle, Martin and Suarez, Felipe and Marcais, Ambroise and Cheminant, Morgane and Rouzaud, Claire and Hermoso, Dea Garcia and Salvator, Hélène and Catherinot, Emilie and Pilmis, Benoit and Luca, Luminita and Brion, Jean-Paul and Revest, Matthieu and Gandemer, Virginie and Lelievre, Lucie and Alvarez, Muriel and Conrad, Anne and Fouyssac, Fanny and Gaud, Catherine and Blumental, Sophie and Blanche, Stéphane and Lortholary, Olivier and Mahlaoui, Nizar and Lanternier, Fanny},
title = {Consecutive non-Aspergillus Fungal Invasive Infections in Chronic Granulomatous Disease: Data from the French National Reference Center for Primary ImmunoDeficiencies and literature review},
journal = {Journal of Clinical Immunology},
year = {2025},
doi = {10.1007/s10875-025-01903-0}
}
EUVIMED